Research graph
References from Direct oral anticoagulants versus warfarin in adult heart transplant recipients. Local targets link to admitted publications; unresolved targets remain external evidence.
Venous thromboembolism in solid-organ transplant recipients: findings from the RIETE registry
10.1016/j.thromres.2021.02.022 · 2021 · External reference
Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report
10.1016/j.chest.2015.11.026 · 2016 · External reference
Venous thromboembolism in heart transplant recipients: incidence, recurrence and predisposing factors
10.1016/j.healun.2014.09.039 · 2015 · External reference
Risk of deep vein thrombosis and pulmonary embolism after heart transplantation: Clinical outcomes comparing upper extremity deep vein thrombosis and lower extremity deep vein thrombosis
10.1111/ctr.12566 · 2015 · External reference
Anticoagulation management strategies in heart transplantation
10.1016/j.pcad.2020.02.002 · 2020 · External reference
10.1111/j.1538-7836.2005.01204.x
10.1111/j.1538-7836.2005.01204.x · 2005 · External reference
Evaluation of direct oral anticoagulation therapy in heart and lung transplant recipients
10.1177/1526924816661951 · 2016 · External reference
Risk of major bleeding in solid organ transplant recipients taking calcineurin inhibitors concomitantly with direct oral anticoagulants compared to warfarin
2017 · External reference
Use of direct oral anticoagulants after heart transplantation
10.1016/j.healun.2019.12.007 · 2020 · External reference
Post transplant thrombosis and atrial arrhythmia may be safely managed by direct oral anticoagulants in cardiac transplant patients
10.1016/j.healun.2016.01.338 · 2016 · External reference
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients
10.1016/j.healun.2022.10.015 · 2023 · External reference
